SNRPC
U1 small nuclear ribonucleoprotein C
Also known as: RU1C_HUMAN, U1-C, Yhc1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P09234
- Gene
- SNRPC
- Ensembl
- ENSG00000124562
- Chromosome
- 6
- Canonical length
- 159 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes one of the specific protein components of the U1 small nuclear ribonucleoprotein (snRNP) particle required for the formation of the spliceosome. The encoded protein participates in the processing of nuclear precursor messenger RNA splicing. snRNP particles are attacked by autoantibodies frequently produced by patients with connective tissue diseases. The genome contains several pseudogenes of this functional gene. Alternative splicing results in a non-coding transcript variant.[provided by RefSeq, Oct 2009]
Canonical amino-acid sequenceUniProt
159 residues, UniProt reviewed canonical sequence.
>P09234|SNRPC
1 MPKFYCDYCD TYLTHDSPSV RKTHCSGRKH KENVKDYYQK WMEEQAQSLI DKTTAAFQQG
61 KIPPTPFSAP PPAGAMIPPP PSLPGPPRPG MMPAPHMGGP PMMPMMGPPP PGMMPVGPAP
121 GMRPPMGGHM PMMPGPPMMR PPARPMMVPT RPGMTRPDRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SNRPC can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.62
- Highest tissue expression
- 194 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 194 nTPM
- bone marrow: 167 nTPM
- skeletal muscle: 164 nTPM
- testis: 125 nTPM
- tongue: 117 nTPM
- thymus: 108 nTPM
Single-cell type
- late primary spermatocytes: 737 nCPM
- hofbauer cells: 331 nCPM
- oocytes: 304 nCPM
- cytotrophoblasts: 281 nCPM
- migrating cytotrophoblasts: 278 nCPM
- extravillous trophoblasts: 250 nCPM
Immune cell
- total PBMC: 246 nTPM
- non-classical monocyte: 240 nTPM
- T-reg: 236 nTPM
- memory B-cell: 235 nTPM
- naive B-cell: 212 nTPM
- plasmacytoid DC: 208 nTPM
Brain region
- white matter: 64 nTPM
- spinal cord: 58 nTPM
- choroid plexus: 57 nTPM
- basal ganglia: 53 nTPM
- thalamus: 53 nTPM
- cerebellum: 53 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SNRPC.
Disease | ImmuneIEDB
Conditions an epitope on SNRPC was assayed in.
- systemic lupus erythematosus B cell
- mixed connective tissue disease B cell
- autoimmune disease of skin and connective tissue B cell
- systemic scleroderma B cell
Disease | AutoantibodyPubMed
Conditions in which antibodies against SNRPC are reported. Each links to that disease's full target list.
ReferencesPubMed · IEDB
Publications for SNRPC from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
3 publications
- Distinctive immune response patterns of human and murine autoimmune sera to U1 small nuclear ribonucleoprotein C protein.
1996 · J Clin Invest · RCR 1 · 39 citations - Human monoclonal autoantibody fragments from combinatorial antibody libraries directed to the U1snRNP associated U1C protein; epitope mapping, immunolocalization and V-gene usage.
1998 · Mol Immunol · RCR 0.4 · 21 citations - Autoantibodies that stabilize U1snRNP are a significant component of human autoantibodies to snRNP and delay proteolysis of sm antigens in vitro.
2004 · J Rheumatol · RCR 0.1 · 3 citations
Reference: B cellIEDB
10 publications
- Linear epitope mapping of an Sm B/B' polypeptide.
1992 · J Immunol · RCR 2.3 · 92 citations - A repeated proline-rich sequence in Sm B/B' and N is a dominant epitope recognized by human and murine autoantibodies.
1990 · J Autoimmun · RCR 0.8 · 30 citations - Early targets of nuclear RNP humoral autoimmunity in human systemic lupus erythematosus.
2009 · Arthritis Rheum · RCR 0.7 · 30 citations - Peptide autoantigenicity of the small nuclear ribonucleoprotein C.
1995 · Clin Exp Rheumatol · RCR 0.7 · 27 citations - A population of autoantibodies against a centromere-associated protein A major epitope motif cross-reacts with related cryptic epitopes on other nuclear autoantigens and on the Epstein-Barr nuclear antigen 1.
2001 · J Mol Med (Berl) · RCR 0.6 · 28 citations
Show 5 more
- Comparison of two different methods using overlapping synthetic peptides for localizing linear B cell epitopes in the U1 snRNP-C autoantigen.
1996 · J Immunol Methods · RCR 0.4 · 17 citations - Human monoclonal autoantibody fragments from combinatorial antibody libraries directed to the U1snRNP associated U1C protein; epitope mapping, immunolocalization and V-gene usage.
1998 · Mol Immunol · RCR 0.4 · 21 citations - Detection of epitopes in systemic lupus erythematosus using peptide microarray.
2018 · Mol Med Rep · RCR 0.4 · 7 citations - A limited lupus anti-spliceosomal response targets a cross-reactive, proline-rich motif.
1998 · J Autoimmun · RCR 0.3 · 12 citations - Epitope mapping of the U1 small nuclear ribonucleoprotein particle in patients with systemic lupus erythematosus and mixed connective tissue disease.
2011 · Lupus · RCR 0.2 · 9 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.56
- gnomAD pLI
- 0.72
- gnomAD missense Z
- 2.55
- DepMap mean gene effect
- -0.79
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- mRNA binding
- protein homodimerization activity
- RNA binding
- single-stranded RNA binding
- zinc ion binding
- pre-mRNA 5'-splice site binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Matrin/U1-C, C2H2-type zinc finger
- Matrin/U1-C-like, C2H2-type zinc finger
- U1-C, C2H2-type zinc finger
- Zinc finger C2H2 superfamily
- U1 zinc finger
- U1 small nuclear ribonucleoprotein C
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SNRPC in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SNRPC as an antibody target. Whether an autoantibody or antibody against SNRPC could matter depends on whether native SNRPC is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SNRPC is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Source-annotated serology context
The source annotations explicitly mention antibody, autoantibody, autoantigen, or autoimmune context. This is biological context, not study-specific reactivity.
- snRNP particles are attacked by autoantibodies frequently produced by patients with connective tissue diseases.
Loading the interactive Seroatlas protein explorer...